By Gekko vs Wolf Editorial Team — April 30, 2025 · 8 min read Executive Summary Guided Therapeutics, Inc. (OTCQB: GTHP) is a misunderstood, microcap medtech company poised to break out. With a market cap hovering under $10 million and a patented device capable of detecting cervical cancer up to two years earlier than conventional […]
By Gekko vs Wolf Editorial Team — May 1, 2025 · 8 min read Apollo Silver (TSX.V: APGO): The Next $10 Silver Breakout By Gekko vs Wolf Editorial Team — May 1, 2025 · 8 min read INTRODUCTION: SILVER’S COMEBACK AND A COMPANY PRIMED TO SURGE Silver has re-entered the global investment spotlight — and
Apollo Silver (TSX.V: APGO): The Next $10 Silver Breakout Read More »
Executive Summary Doubleview Gold Corp. (TSX.V: DBG) isn’t your average junior. This is a company with its foot firmly planted in one of the most consequential mineral stories of the next decade. While short-term trading often overlooks strategic value, Doubleview’s Hat Project has garnered attention from sovereigns, majors, and strategic investors evaluating scandium’s long-term potential.
